Gastric cancer
Three patients with GC were enrolled in this study. Two patients could be evaluated for efficacy and were still in follow-up, of which the best efficacy was PR, and PFS was not reached. The response rate of this study in GC was higher than that of immunotherapy combined anti-angiogenic therapy or immunotherapy combined chemotherapy (